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Bovine immunodeficiency virus (BIV) is a lentivirus with no proven pathogenesis in infected cattle. Yet, in experimentally infected rabbits, it
causes an AIDS-like disease. Consequently, we expressed two recombinant isoforms of BIV reverse transcriptase (RT), which differ in their C-
termini, and studied their catalytic properties. Both isoforms prefer Mg+2 over Mn+2 with most DNA polymerase and ribonuclease-H substrates.
The processivity of DNA synthesis by the BIV RTs is higher than that of HIV-1 RT, whereas the fidelity of synthesis is even lower than that of the
HIV-1 enzyme. The ribonuclease-H cleavage pattern suggests that the spatial distance between the polymerase and ribonuclease-H active sites of
the two BIV RT isoforms equals 20 nt, unlike the 17 nt distance observed in almost all other RTs. The longer BIV RT version is somewhat less
active than the shorter version, suggesting that the extra 74 residues (with homology to dUTPases) might obstruct efficient catalysis.
© 2006 Elsevier Inc. All rights reserved.Keywords: Bovine immunodeficiency virus; Retrovirus; Reverse transcriptase; Lentiviruses; Human immunodeficiency virus; DNA polymerase; Ribonuclease H;
ProteaseIntroduction
The bovine immunodeficiency virus (BIV) is a member of
the lentivirus subfamily of retroviruses, a group of exogenous,
nononcogenic viruses that cause chronic, multi-system disease
in susceptible hosts (Gonda et al., 1987; Narayan and Clements,
1989). BIV was first isolated from a dairy cow with persistent
lymphocytosis, lymphoid hyperplasia, central nervous system
lesions and progressive weakness (Van der Maaten et al., 1972).
Serological studies indicate that BIV is present worldwide
(Cockerell et al., 1992; Forman et al., 1992), seropositivity for
BIV has been correlated with decreased milk production in
dairy cattle (McNab et al., 1994). An increased incidence of
encephalitis and secondary bacterial infections has been
reported in herds with high BIV seroprevalence (Snider et al.,⁎ Corresponding author. Fax: +972 36407432.
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doi:10.1016/j.virol.2006.03.0121996). However, there is no conclusive evidence that BIV is the
direct cause for the etiology of these syndromes. Such a
demonstration is complicated by the co-infection with bovine
leukemia virus (BLV), another retrovirus belonging to the
HTLV/BLV group (Flaming et al., 1993, 1997). Lentivirus
infections are typically characterized by the establishment of a
persistent, lifelong infection and a slow, progressive disease
course in the naturally infected host. There is wide variation in
clinical disease both among and within the different members of
the lentivirus subfamily. The pathogenesis of BIV still remains
unknown in infected cattle and buffaloes, as no virus-specific
diseases have been identified in acutely infected herds.
Interestingly, BIV induces in experimentally infected rabbits
clinical syndromes, including fatal immune dysfunctions
similar to AIDS induced in humans by human immunodefi-
ciency virus (HIV), in monkeys or in cats by the simian or feline
immunodeficiency viruses, respectively (SIV and FIV) (Kal-
vatchev et al., 1995, 1998).
BIV resembles other lentiviruses in certain aspects of its
pathogenesis, ultrastructure, genome organization and infec-
tious cycle in susceptible cells (Braun et al., 1988; Garvey et al.,
1990; Gonda et al., 1987). This nonprimate lentivirus resembles
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was, therefore, named BIV to reflect its genetic relationship
and biological similarity to HIV (Gonda et al., 1987).
Nevertheless, BIV is unable to infect human cells (Gonda et
al., 1994). In terms of genome organization, BIV is the most
complex nonprimate lentivirus. In addition to the obligate
retroviral gag, pol and env structural genes, BIV encodes six
putative nonstructural/accessory genes; vif, tat, rev, vpw, vpy
and tmx (Garvey et al., 1990; Gonda, 1994, 1987; Oberste
and Gonda, 1992; Oberste et al., 1991, 1993). GeneticFig. 1. Clustal W pairwise alignment of the amino acids residues encoded by the po
upper lines represent the amino acids sequences of BIV PR and RT (and the amino-ter
RTs are 546 and 620 residues-long. BIV RT1 carboxyl terminus aligns with HIV-1 RT
before the alignment with the amino terminus of HIV-1 IN. Asterisks in the lower lines
left of each line. (AT) denotes amino terminus and (CT) denotes carboxyl terminus.variability is an outstanding feature of lentiviruses, contrib-
uting to the pathogenesis of these viruses by enabling them to
persist in the host and evade anti-retroviral treatments. As
shown for known lentiviruses, isolates of BIV exhibit a
striking genomic diversity, located mainly in the viral
envelope gene (Meas et al., 2001). However, assessment of
the extent of variation in the reverse transcriptase (RT)
domain of the pol gene revealed that this is one of the most
conserved regions of the genome. The RT region of BIV
genome, like that of HIV, is subjected to purifying selectionl genes of BIV and HIV-1 (of the BIV127 and BH-10 strains, respectively). The
minus of integrase). Recombinant BIV PR is 105 residues-long and recombinant
carboxyl terminus, RT2 carboxyl terminus is the last residue in the BIV sequence
mark the identical amino acids. The numbers of the residues are indicated on the
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progenitor (Cooper et al., 1999).
Reverse transcriptase is a key enzyme in the life cycle of all
retroviruses (Coffin et al., 1997; De Clercq, 1997; Skalka and
Goff, 1993). The replication of these viruses starts with the
reverse transcription of the single-stranded viral RNA genome
to double-stranded DNA, which is subsequently integrated into
the host cell chromosomal DNA. This complex process of
proviral DNA synthesis, which is highly critical to retroviral life
cycle, is catalyzed by a single enzyme, the viral RT, by
employing its various activities. The plus-strand RNA genome
is copied by the RNA-dependent DNA polymerase (RDDP)
activity of RT, producing RNA–DNA heteroduplexes. Con-
comitant with this synthesis, the ribonuclease-H (RNase H)
activity of RT specifically hydrolyzes the RNA strands in these
RNA–DNA hybrids and the remaining DNA strands are copied
into the complementary DNA strands by the DNA-dependent
DNA polymerase (DDDP) activity of RT (generating double-
stranded DNA). Due to its critical role in retroviral replication,
inhibitors of RT are effective in inhibiting viral propagation
(Coffin et al., 1997).
Due to the potential uniqueness of BIV RT, we have
expressed this novel lentiviral RT and studied its catalytic
properties. Here, we report on the expression in Escherichia coli
of the enzymatically active recombinant BIV RT. This RT is
derived from a pBIV127, a plasmid containing the complete and
infectious proviral BIV genome sequence (Braun et al., 1988).
Because of the relatively low sequence homology with other
RTs at the carboxyl terminus (see Fig. 1), we have expressed
two recombinant versions of BIV RT that differ in length at their
carboxyl termini. Consequently, a comparative study on the
catalytic and molecular properties of these two RTs was
conducted, thus allowing the prediction of the most effective
carboxyl terminus. The recombinant BIV RTs show high
catalytic activities, resembling in most cases those of HIV-1 RT.
Expressing and investigating the molecular and catalytic
properties of BIV RT can potentially allow a better understand-
ing of the closely related HIV-1 RT. Moreover, this knowledge
can allow targeted drug design against lentiviral diseases,
including acquired immunodeficiency syndrome (AIDS).
Results
Plasmids construction for protein expression
Two recombinant BIV RTs were designed based on the
sequence homology of BIV pol gene with HIV-1 pol gene (Fig.
1), both share the same amino terminus and differ in their
carboxyl termini. A comparison between the pol genes of both
HIV-1 and BIV revealed that the best fit between HIV-1 RT (560
amino acids in length) and BIV RT is obtained when the BIV
RT protein starts at its amino terminus with the sequence NH2-
VHTEKI and ends at the carboxyl terminus with the sequence
ALEQMA-COOH. This gives a BIV RT protein that is 546
amino acids in length. In most retroviruses, the integrase (IN)
protein is encoded by the genomic sequence that is adjacent
immediately downstream to the RT-coding sequence (Foms-gaard et al., 1991; Kirchhoff et al., 1990; Mang et al., 2001;
Martoglio et al., 1997; Takehisa et al., 2001). Therefore, it was
surprising to see that the sequence similarity between BIV IN
and HIV-1 IN starts 74 residues downstream to the putative
carboxyl terminus of BIV RT and there is no sequence homolog
in HIV-1 for this protein segment. As we could not predict
whether this segment is part of the BIV RT, we have expressed
two versions of the recombinant BIV RTs. The first one,
designated RT1, is the 546 residues long BIV RT. The second
BIV RT version is longer and includes at the carboxyl terminus
the extra 74 residues segment. Therefore, this RT version,
designated RT2, is 620 residues long and ends at its carboxyl
terminus with VFMTC-COOH, immediately adjacent to the
FLEN sequence that is the putative amino terminus of the BIV
IN (see Fig. 1).
The genomes encoding the genes for the expression of the
BIV RT isoforms (and protease—see below) were synthesized
by PCR using as a template the pBIV127 plasmid that contains
the genome of an infectious molecular clone of BIV (Braun et
al., 1988) as described in detail in Materials and methods. All
known lentiviral RTs are composed of heterodimeric proteins
where the longer subunit (for example, the p66 or p68 subunit in
RTs of HIV-1 or HIV-2, respectively) is cleaved at their
carboxyl termini by the viral protease (PR) removing the RNase
H domain and yielding a shorter subunit (as p51 or p54, giving
rise to the heterodimeric RT forms, p66/p51 or p68/p54, in HIV-
1 or HIV-2, respectively). One successful way to create such
recombinant RTs is to co-express simultaneously by the same
plasmid vector both the RT the PR proteins, assuming that in the
expressing bacteria the PR will cleave the RT to generate the
authentic heterodimeric RTs (Coffin et al., 1997; DeVico et al.,
1989; di Marzo Veronese et al., 1986; Gao et al., 1998; Sevilya
et al., 2001; Skalka and Goff, 1993). Therefore, the BIV RT-
expressing vectors, constructed by us, also induce the synthesis
of the 105 residues-long BIV PR (according to the sequence
shown in Fig. 1). The simultaneous expression of the BIV RT
versions and PR was done in Bl21 E. coli under the control of
the phage T7 promoter (see Materials and methods). Both RT
versions were designed to contain at their amino termini a six-
histidines tag to allow rapid purification of the enzymes. The
plasmid designations are pT5m-6His-BIV RT1/PR and pT5m-
6His-BIV RT2/PR, for the shorter and the longer BIV RT
versions, respectively. The bacterial clones harboring these
plasmids were analyzed for the expression of BIV RT using two
methods. First we have tested the RDDP activity of the
recombinant RTs in bacterial lysates, as done by us earlier (Hizi
and Hughes, 1988; Perach and Hizi, 1999; Taube et al., 1998b).
Second, we have employed Western blot analyses with anti-His
tag antibodies. Both methods clearly indicated an expression of
soluble and enzymatically active RT species.
Purification of BIV RTs
The BIV RTs were purified to homogeneity, employing
the Ni-NTA agarose affinity chromatography, designed to
selectively bind the six histidines tag-containing proteins,
followed by carboxymethyl (CM)-Sepharose ion-exchange
Fig. 2. SDS/PAGE analysis of the purified recombinant BIV RTs. The purification of BIV RTs was performed as described in Materials and methods and in the text.
The purified BIV RT1 and BIV RT2, marked as BIV(1) and BIV(2), respectively, were analyzed by 7.5% SDS/PAGE. The gels were then stained with Coomassie (A)
or underwentWestern blot analysis with HRP-conjugated anti-6-Histidines rabbit antiserum, purchased from Sigma (performed as described previously (Entin-Meer et
al., 2002) (B). The apparent molecular sizes of the PERV RT and the subunits of HIV-1 RT are shown (left), and the molecular sizes of the subunits of the preparations
recombinant BIV RTs are marked (right).
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other RTs (Avidan et al., 2003; Perach and Hizi, 1999; Sevilya
et al., 2001; Taube et al., 1998b). The pT5m-6His-BIV RT1/PR
plasmid induces the synthesis of a heterodimeric protein with
two subunits with molecular sizes of approximately 64 and
51 kDa at roughly an equimolar ratio. The larger subunit of RT1
is compatible with the expected full length of the RT1 546
residues recombinant protein (Fig. 2). Since a parallel
purification of RT1, expressed from a plasmid that lacked the
PR genome, yielded only the 64 kDa polypeptide (data not
shown), it is highly likely that the p51 polypeptide is the product
of the p64 subunit, and it was generated by the specific
proteolytic activity of BIV-encoded PR. In HIV-1, the PR
removes from the larger RT subunit a segment of 120 residues,
generating the p51 subunit (see the cleavage point in Fig. 1).
The size of the shorter BIV1 RT subunit is compatible with a
similar PR-dependent cleavage that generates a BIV RT subunit
of about 420 residues in length. This suggests that the cleavage
specificity of the novel BIV PR is similar to that of HIV-1 PR.
As to the polypeptides synthesized by the pT5m-6His-BIV
RT2/PR plasmid, a substantial portion of the full length subunit,
induced by this plasmid, is about 72 kDa in size that is
compatible with the expected 620 amino acid-long polypeptide
(Fig. 2). The smaller subunit of RT2, generated in the induced
bacteria by apparently the BIV-encoded PR cleavage, shows the
same length as the small subunit of RT1. This suggests that, as
expected, the protease cleavage site in the two novel BIV RTTable 1
The quantitative pattern of BIV RTs purification from bacterial extracts
BIV RT1
Protein
(mg)
DNA polymerase
activity (units)
Specific DNA
activity (unit
Crude bacterial extract 480 4.8 × 103 1 × 10−2 (1)
Ni-NTA agarose column eluate 3 6.8 × 105 227 (2.3 × 10
CM-sepharose column eluate 1.9 9.6 × 106 5065 (5 × 10
The DNA polymerase activity is expressed in units. A unit is defined as 1 pmol of [3H
(rA)n·oligo(dT)12–18-directed reaction, as described in “Material and methods”. The f
RDDP activity of the purified protein increased relative to that of the crude bacteriaversions is similar (Fig. 2). Nevertheless, beside the two
subunits, there is an additional polypeptide of about 69 kDa,
slightly shorter than the large RT2 subunit. Since these two
polypeptides (as well as the p51 subunit) were recognized by
anti-his tag antibodies, as seen in a Western blot analysis (Fig.
2B), it is conceivable that they share the same amino terminus
and differ only at their carboxyl termini. On the other hand,
purification of BIV RT2 from the expressing bacteria, harboring
a plasmid that lacks the PR gene, resulted in obtaining the same
p72 and p69 polypeptides (data not shown). Taken together, it is
evident that the formation of the smaller 51 kDa subunit in both
RT versions is due to a specific proteolytic cleavage by the BIV
PR, whereas the generation of the p69 polypeptide of RT2 is
likely to be due to either proteolysis of the 72 kDa subunit by
nonspecific bacterial proteases or by premature termination of
the synthesized protein.
A quantitative analysis of the purification steps follows the
extent of increase of the specific activity of the two novel ver-
sions of BIV RT (Table 1). The first affinity purification step on
Ni-NTA has lead to a huge increase in the specific DNA
polymerase activity of both BIV RT versions (of 3600-fold to
23,000-fold for RT2 and RT1, respectively). This increase is due
to a combination of both removals of bacterial proteins and, not
less importantly, a dramatic increase in the total polymerase
activity by about 150-fold. After the CM-Sepharose ion ex-
change chromatography, there is a second, although a less pro-
nounced, increase in the specific DNA polymerase activity, ofBIV RT2
polymerase
s/μg protein)
Protein
(mg)
DNA polymerase
activity (units)
Specific DNA polymerase
activity (units/μg protein)
210 1.5 × 103 7.2 × 10−3 (1)
4) 9 2.3 × 105 25.7 (3.6 × 103)
5) 1 1.1 × 106 1057 (1.5 × 105)
]dTTP incorporated into TCA-insoluble material in 30 min at 37 °C in the poly
igures in parenthesis are the purification fold, i.e. the factor by which the specific
l extract.
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(Table 1). At this purification step, there is still a mild increase
(5–14-fold) in the total DNA polymerase activity. Taken
together, both versions of the novel BIV RT underwent
extensive purifications; with a massive increase in the specific
activity (of more than 100,000-fold). The increase in the total
RT activity precludes the calculation of the relative recovery of
the BIV RTs during the purification process. We have observed
previously a similar phenomenon of an overall increase in the
total DNA polymerase activity throughout the purification of
the recombinant RTs of MMTV (Taube et al., 1998b), BLV
(Perach and Hizi, 1999) and porcine endogenous retrovirus
(PERV) (Avidan et al., 2003). This phenomenon can be
explained by a removal of bacterial components that strongly
inhibit RT activity.
The relative DNA polymerase activities
The enzymatic activities of BIV RT1 and BIV RT2 were
analyzed in the presence of 0.8 mM Mn+2 or 8 mM Mg+2,
allowing also a comparison of the activities and the divalent
cation preferences of the two BIV RT isoforms. These two
concentrations of divalent cations were chosen, since we had
found in preliminary experiments that they were the optimal
concentrations for the activity of both BIV RT isoforms (data not
shown). Previous data show that retroviral RTs differ in their
divalent cation preferences (Avidan et al., 2003; Hizi and
Hughes, 1988). As already reported earlier (Avidan et al., 2003;
Perach and Hizi, 1999; Skalka and Goff, 1993; Taube et al.,
1998b), we also show here that this preference of the two RT
isoforms depends on the substrate used for assaying RT
activities. The relative specific activities of the BIV RTs with
a variety of substrates used are presented in Table 2. Like all RTs
studied so far, both versions of the new BIV RT have the RDDP
and DDDP activities as well as an intrinsic RNase H activity. It isTable 2
Specific catalytic activities, substrates and divalent cation preferences of BIV
RT1 and RT2
RT
activity
Substrate BIV RT1 BIV RT2
Mg+2 Mn+2 Mg+2 Mn+2
DDDP dA·dT 185 ± 4 365 ± 0.5 153 ± 3 175 ± 4
dC·dG 708 ± 16 217 ± 8 551 ± 41 137 ± 8
Activated DNA 144 ± 6 65 ± 4 80 ± 8 23 ± 3
RDDP rA·dT 7800 ± 200 4120 ± 20 3860 ± 75 2080 ± 30
rC·dG 552 ± 14 57 ± 0.4 567 ± 30 48 ± 2
RNase H [3H]rA·dT 91 ± 11 72 ± 5 43 ± 3 0
The DNA polymerase-specific activities are expressed in pmol of dNTP
incorporated into DNA in 30 min at 37 °C per μg purified RT. For activated
DNA, the dNTP incorporation was calculated for all four dNTPs, assuming
equimolar incorporation. The specific RNase H activity was expressed in pmol
[3H]AMP released from [3H]poly(rA)n·poly(dT)n in 30 min at 37 °C per μg
protein (as described in “Material and methods”). The different catalytic
activities were determined in the presence of either 0.8 mM MnCl2 or 8 mM
MgCl2. The values presented are averages calculated from four independent
experiments (after subtracting background levels with no RT present in the
reaction) ± the standard deviations. The specific activities values marked in bold
figures are the maximal ones obtained for each RT (for every given substrate)
while comparing the Mg+2-dependent versus the Mn+2-dependent reactions.apparent that both BIV RT isoforms preferMg+2 overMn+2 with
all substrates used to assay both the DNA polymerase and the
RNase H activities, except for one substrate, poly(dA)n·oligo
(dT)12–18. It is also obvious that, for both RT versions, the
specific preferences for the template-primers, employed for the
polymerase activities, show similar selections. As for the RDDP
function of almost all studied RTs, the BIV RT isoforms exhibit
higher activities with poly(rA)n·oligo(dT)12–18 than with poly
(rC)n·oligo(dG)12–18. To assay the DDDP activity, we have used
both synthetic substrates and activated DNA, prepared by a
limited digestion of herring sperm DNAwith pancreatic DNase I
to create single-stranded gaps (Hizi et al., 1991b). Here, the
order of preference with the various template-primers is as fol-
lows:poly(dC)n·oligo(dG)12–18>poly(dA)n·oligo(dT)12–18>ac-
tivated DNA. It is also evident that, for almost every given
substrate and divalent cation employed, BIV RT1 exhibits a
specific activity somewhat higher than that observed with BIV
RT2 (except for the poly(rC)
n
·oligo(dG)12–18-directed DNA
polymerase activity, where the activities of the two isoforms are
very similar). The [3H]poly(rA)n·poly(dT)n-directed RNase H
activity measured is also higher for RT1 relative to RT2 with a
preference for Mg+2 over Mn+2. Interestingly, RT2 does not
show any detectable activity in this specific assay in the presence
of Mn+2. The preference for Mg+2 as the divalent cation, found
in this study, is in line with most retroviral RTs, except for
mammalian type C retroviruses RTs (Avidan et al., 2003; Hizi
and Joklik, 1977; Kohlstaedt et al., 1992; Taube et al., 1998b).
Steady-state kinetic parameters for the DNA polymerase
activity
The kinetics for the incorporation of the relevant dNTPs into
the nascent DNA strand were determined for both BIV RT
isoforms from the double reciprocal plots of the initial velocity
of dNTP incorporation versus substrate concentration (not
shown). For RDDP activity, we have tested variable concentra-
tions of dTTP with poly(rA)n·oligo(dT)12–18 and the variable
dGTP with poly(rC)n·oligo(dG)12–18. For the DDDP function,
dTTP or dGTP were the variable substrates with activated
gapped double-stranded DNA as the template-primer (with
dATP and dCTP at a constant concentration). To examine the
kinetic parameters under optimal conditions, the divalent cation
used in each reaction with all the template-primers studied was
the preferable one, Mg+2 (see Table 2). The results presented in
Table 3 show that BIV RT1 is somewhat more efficient as a
DNA polymerase relative to RT2, as deduced from the kcat/Km
values calculated. This higher efficiency of BIV RT1 is espe-
cially pronounced with the parameters calculated for dTTP in
the poly(rA)n·oligo(dT)12–18-directed assay (an 8.5-fold differ-
ence). In this case, both a lower Km value and a higher turnover
number (kcat) contribute to the substantially higher value calcu-
lated for RT1. In all, the values calculated are quite similar to
comparable ones calculated for the recombinant RTs of HIV-1,
EIAV, BLV and MMTV and are lower than those of the RTs of
HIV-2, MLV and PERV RTs (Avidan et al., 2003; Hizi et al.,
1991b; Perach and Hizi, 1999; Rubinek et al., 1994; Taube et al.,
1998b).
Table 3
Steady-state kinetic parameters for DNA polymerase activities of BIV RT1 and
BIV RT2
rA·dT
(dTTP)
rC·dG
(dGTP)
Activated DNA
(dTTP) (dGTP)
BIV RT1
Km(M) 4.8 × 10
−6 2.8 × 10−6 6.0 × 10−7 2.2 × 10−6
kcat(s
−1) 403 33 9.9 12.8
kcat/Km(M
−1 s−1) 8.5 × 107 1.2 × 107 1.7 × 107 5.8 × 106
BIV RT2
Km(M) 1.8 × 10
−5 2.9 × 10−6 8.2 × 10−7 3.2 × 10−6
kcat(s
−1) 182 26 8.2 11.2
kcat/Km(M
−1 s−1) 1.0 × 107 9.0 × 106 1.0 × 107 3.5 × 106
The RDDP and DDDP activities of BIV RT1 and BIV RT2 were assayed with
the specific template-primers, and variable concentrations of either dTTP or
dGTP, as described in “Material and methods” section. All reactions were carried
out for 10 min at 37 °C. The Km and Vmax values were determined from the
double reciprocal plots of the various substrate concentrations against the initial
velocities of DNA synthesis. The plots were generated by linear regression
analysis, yielding regression coefficients around 0.99 (not shown). The kcat values
are the steady state rate coefficients calculated from the Vmax values divided by
the moles of each enzyme present in the reactions. Km values are expressed in M
of the variable dNTP and the kcat values in s
−1 and the kcat/Km values in s
−1 M−1.
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During enzymatic polymerization reactions, the lengths of
the nascent polymeric products, formed before the polymerase
molecules dissociate from them, define the processivity features
of the enzyme (Avidan and Hizi, 1998; Von Hippel et al., 1994).Fig. 3. DNA synthesis under processive and nonprocessive conditions exhibited by
labeled primer and an excess of the template single-stranded circular ϕX174am3 ph
primer is shown in Fig. 6A. The symbols for the DNA synthesis experiments are
experiments conducted in the presence of 0.6 mg/ml unlabeled trap of activated DNA
donor; (Mn+2) reactions performed with 0.8 mMMnCl2. Molecular mass markers we
(Promega) labeled with γ[32P]ATP at the 5′-ends by polynucleotide kinase (not shoThe extent of product elongation in one cycle of synthesis
depends on parameters that affect binding, single nucleotide
addition, translocation, pausing, etc. Retroviral RTs are known
to be inefficient in performing fully processive polymerization
events (Avidan and Hizi, 1998; Avidan et al., 2003). Therefore,
we have tested the processivity of the novel isoforms of the
recombinant BIV RT by examining their capacity to synthesize
DNA, using a template of single stranded ΦX174am3 DNA
(Fig. 3). This was done in the presence of Mg+2 or Mn+2 as the
divalent cation in the reaction mixture and in comparison with
the well-studied RTs of HIV-1 and MLV, each in the presence of
its preferred divalent cation (Avidan and Hizi, 1998; Avidan et
al., 2003). The extension of the 5′-end [32P]-labeled primer was
carried out in the absence or presence of an excess of unlabeled
activated DNA, which was added after preincubating the
enzymes with the labeled template annealed to primer (and prior
to initiating polymerization by adding the four dNTPs). This
unlabeled DNA serves to trap the enzyme that dissociates from
the template-primer after the first cycle of DNA synthesis is
completed. As this DNA trap prevents further extensions of the
labeled primer, due to re-association of the RT, each end-labeled
polymerized molecule is restricted to a single round of DNA
synthesis. As expected, both BIV RT isoforms make longer
DNA products when multiple rounds of synthesis are permitted
when no trap is present. The enzymes used have been calibrated
to have equal DDDP activities with ΦX174am3 DNA (Fig. 3).
In the absence of the DNA trap, the distributions of the products
(generated by both RTs) show a significant preference for Mg+2.
The overall primer extension of both BIV RT isoforms in theBIV RT. All reactions were performed with the 15-nucleotide synthetic 5′-end-
age, DNA as shown previously (Avidan and Hizi, 1998). The sequence of the
as follows: (−) DNA extension performed without DNA trap; (+) extension
(Avidan et al., 2003). (Mg+2) reactions with 8 mMMgCl2 as the divalent cation
re HinfI-cleaved dephosphorylated double-stranded ϕX174am3 DNA fragments
wn).
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HIV-1 and MLV, as can be also seen from the qualitative results
(Fig. 3).
The extension products were also quantified and the
elongation was calculated as a percentage of the total amount
of primers (both unextended and extended primers—Table 4).
The qualitative and quantitative data indicate that both BIV RT
isoforms extend (in the presence of Mg+2 as the preferred
divalent cation) the majority of the primers molecules, when
multiple rounds of DNA synthesis are permitted (i.e. without a
trap). BIV RT1 extends in the presence of Mg+2 approximately
the same proportion of the primers (about 91%) compared to
BIV RT2 (about 89%). The majority of the products of both RTs
(of about 61%) are longer than 100 nt. As can be seen in Fig. 3
and similar to other RTs (Avidan and Hizi, 1998; Avidan et al.,
2002, 2003; Taube et al., 1998a), there are specific pausings
during DNA synthesis, which are quite similar for both BIV RT
isoforms and are common to the two other RTs, analyzed here.
These pausing sites do not seem to depend on whether Mg+2 or
Mn+2 are present. On the other hand, the length of the products
depends substantially on the divalent cation used. The products
generated with the unfavorable cation are shorter, suggesting
that the translocation (or what we define as “persistence of
synthesis”) is impaired, even when multiple rounds of synthesis
are allowed. When a DNA trap is present, and only one round of
DNA synthesis is permitted, both RTs synthesize less and
shorter products relative to multiple-round synthesis (Fig. 3 and
Table 4). Additionally, the ratio calculated for the overall
extension with a trap, over that without a trap (which equals toTable 4
Quantitative analysis of DNA primer extension
Product length
(nt)
Mg+2 Mn+2
No trap With trap Ratio No trap With trap Ratio
RT1
16–50 15.4 19.5 1.3 33.6 34.0 1
51–100 15.0 13.6 0.9 21.2 7.6 0.36
101–250 42.0 41.3 0.98 20.8 12.7 0.6
>250 18.9 13.1 0.7 7.9 0.6 0.08
Overall extension 91.3 87.5 0.96 83.5 54.9 0.66
RT2
16–50 13.7 20.8 1.5 33.4 11.5 0.34
51–100 14.6 15.9 1.09 21.3 7.0 0.33
101–250 43.1 38.5 0.89 21.6 14.0 0.65
>250 17.9 9.3 0.52 6.7 3.7 0.55
Overall extension 89.3 84.5 0.95 83.0 36.2 0.44
The radioactivity in the DNA bands in all polynucleotide length ranges was
summed up and the values were divided by the sums of all extended and
unextended primers (detected in the scanning of the gels autoradiogram as shown
in Fig. 3). The values given are the extended primers, in each product length
range, expressed as percentages of the total amounts (all extended and
unextended primers) of the DNA products. The calculations were conducted
separately for gel lanes of reactions carried out in the absence or presence of an
excess of the unlabeled DNA trap. The extensions in the presence of the DNA
trap divided by the comparable figures (obtainedwith no trap present) yielded the
ratio values. The ratios calculated for the overall extensions are the relative
processivity values. The values are the means calculated from two independent
experiments (one of which is shown in Fig. 3) and the variations were less than
10%.the relative overall processivity values) for both recombinant
BIV RTs, is significantly higher (by up to 2.3-fold) with Mg+2
over Mn+2. In conclusion, it is apparent that both enzymes are
more processive than the RTs of HIV-1 and MLV, these results
are in agreement with former studies (Avidan and Hizi, 1998;
Avidan et al., 2002, 2003). The overall processivity of DNA
synthesis of RT1 over RT2 is about the same in the presence of
Mg+2, but with Mn+2 RT1 functions better than RT2.
The RNase H activity
All RTs have an intrinsic RNase H activity that is
fundamental for the process of reverse transcription. Sequence
and structural analyses have shown that the RNase H domain is
located in the carboxyl terminus of the RTs, whereas the DNA
polymerase at the amino terminal portion of the molecule. To
confirm the presence of the RNase H activity in the novel BIV
RT and to characterize it, two assay methods were employed
(Gao et al., 1998; Hizi et al., 1991a; Sevilya et al., 2001). In the
first method, the release of [3H]AMP was followed as a result of
the digestion of [3H]poly(rA)n·poly(dT)n and in the second, the
pattern of cleavage of labeled RNAwith a defined length in an
RNA–DNA heteroduplex has been followed (see Materials and
methods). The data obtained indicate that the BIV RT isoforms
exhibit, like most RTs studied so far, an RNase H activity with a
significant preference for Mg+2 over Mn+2 (Table 2 and Fig. 4).
It is also apparent that the specific RNase H activity of BIV RT1
is significantly higher than that of BIV RT2 with both divalent
cations.
The pattern of the cleavage of the 5′-end-labeled 267 nt RNA
was used to characterize the RNase H activity of the RTs of
HIV-1 and HIV-2 (Gao et al., 1998; Sevilya et al., 2001) as well
as those of PERV, MLV (Avidan et al., 2003) and mouse
mammary tumor virus (MMTV) (Entin-Meer et al., 2002). All
these RTs usually perform two cleavages. First, a primary
cleavage takes place at a position 17 nt away from the position
corresponding to the 3′-end of the DNA heteroduplex (thus,
producing in the specific assay employed, a 47-nt-long RNA
product). Since it is assumed that the DNA polymerase domain
of the RT binds the 3′-end of the DNA primer, this primary
cleavage suggests that the molecular distance between the DNA
polymerase active site and the RNase H active sites equals to 17
nt. In many RTs, there is also a secondary RNase H cleavage at a
position that corresponds to 8 nt away from the 3′-end of the
DNA (producing in this assay 38 nt-long RNA molecules). This
probably results from a secondary repositioning of the RT
molecules in the RNA–DNA heteroduplexes after performing
the primary cleavage (Gao et al., 1999; Palaniappan et al., 1996;
Sevilya et al., 2001; Wisniewski et al., 2000). The primary
cleavage performed by HIV-1, HIV-2, MMTV, MLVand PERV
RTs produces a similar 47 nt-long product (Avidan et al., 2003;
Gao et al., 1999; Sevilya et al., 2001; Wisniewski et al., 2000).
As seen in Fig. 4, both BIV RT isoforms show a pattern of
RNase H primary cleavage, that is different than the one
obtained with HIV-1 RT and hence with all above mentioned
RTs, producing a 50-nt-long RNA product. This result suggests
that in BIV RT the putative spatial distance between the RNase
Fig. 4. The RNase H activity of BIV RT. The scheme in the upper panel describes the principle of the reaction and the lengths of the cleavage products of the BIV RT
isoforms, which differ from those of HIV-1 RT (see text). The RNase H activity of BIV RT1 and BIV RT2 was compared with RNase H activity of HIV-1 RT
employing the assay described in Materials and methods. Fifty nanograms of each highly purified RT was incubated with the RNase H substrate (the 5′-end-labeled
267 nt RNA and oligomeric DNA) at 37 °C, for the indicated times (0.25, 1 and 2 min). The reactions were performed with either Mg+2 or with Mn+2. The products
were resolved by urea-PAGE. The sizes of the cleavage products were determined using an RNA size markers ladder. The 5′-end-labeled RNA marker ladder was
prepared by incubating the 5′-end-labeled 267 nt RNA in 10 mM NaOH for 30 s at 50 °C (not shown). Lane C shows the product of a mixture with no RT present.
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Interestingly, both BIV RT isoforms perform a secondary
cleavage that produces 38 nt-long RNA molecules that
correspond to a −8 nt cleavage (Fig. 4). This indicates that
the repositioning of BIV RT1 and RT2, after performing the
primary RNase H cleavage, is similar to that of HIV-1 RT, as
well as HIV-2 RT and MMTV RT (Entin-Meer et al., 2002;
Sevilya et al., 2001). Another conclusion is that the RNase H
activity of both BIV RT isoforms is weaker than that of HIV-1
RT.
The results of the RNase H activity detected in two
independent experiments (one of which is shown in Fig. 4),
were also quantified and the percentages of each cleavage are
shown in Table 5. Compatible with the data presented in Table 2
for the [3H]poly(rA)n·poly(dT)n-directed RNase H activity, BIV
RT1 has substantially higher RNase H activity than RT2. RT1
performs almost equally well with either one of the two divalent
cations. However, RT2 shows a significant preference for Mg+2
over Mn+2. Still, RT2 has a substantial activity with Mn+,
despite the fact that in the [3H]poly(rA)n·poly(dT)n-directedassay there was no detectable activity with this divalent cation
(Table 2 and Table 5). It is also apparent that the qualitative
pattern of RNase H cleavage with Mg+2 or Mn+2 is quite similar
for the two BIV RT isoforms. BIV RT2 is longer than RT1 by 74
amino acid residues; the addition is on the carboxyl terminus of
the enzyme. Since RNase H domain is located in the carboxyl
terminus of the RTs, it might be that the extra 74 residues in the
longer RT version interfere with the RT structure needed for
efficient RNA cleavage. This can explain why RT2 has a lower
RNase H activity relative to RT1.
The strand transfer activity
During the process of reverse transcription of the retroviral
RNA genome into double-stranded DNA, there are two
template-switches or strand transfers (Coffin et al., 1997).
Both the DNA synthesis and RNase H functions of RT are
simultaneously involved in this process (Gao et al., 1998;
Peliska and Benkovic, 1992). The RNase H activity cannot
cleave the 5′-end of the viral RNA until the minus strand strong
Table 5
Kinetics of RNase H primary and secondary cleavages
BIV RT1 BIV RT2 HIV-1 RT
Mg+2 Mn+2 Mg+2 Mn+2
15″ 2′ 15″ 2′ 15″ 2′ 15″ 2′ 15″ 2′
1st cleavage 49 ± 1.1 5.9 ± 0.3 51 ± 3 12 ± 1.1 7.5 ± 0.6 4.6 ± 0.2 5.7 ± 0.6 29 ± 1.4 69 ± 0 0
2nd cleavage 6.5 ± 0.5 78 ± 1.2 5.5 ± 0.4 63 ± 1.8 1.6 ± 0.2 64 ± 2.5 0.2 ± 0 10 ± 1.3 31 ± 0 100
Total cleavage 56 ± 1.6 84 ± 1.5 57 ± 3.4 75 ± 2.9 9.1 ± 0.8 69 ± 2.7 5.9 ± 0.6 39 ± 2.7 100 100
The radioactivity in the RNA bands of both first and second cleavages and the 267 nucleotides-long substrate was summed up and the values were subsequently
divided by the total amounts, which are the sums of all cleaved and uncleaved labeled RNA bands (detected by scanning of the gels autoradiogram, one of which is
shown in Fig. 4). The values given are the cleavage products, expressed as percentages of the total amounts. The calculations were conducted separately for gel lanes of
reactions carried out with either Mg+2 or with Mn+2, at 37 °C, for the indicated times.
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newly synthesized DNA to be released from the original RNA
template, so it can re-anneal to the 3′-end of the RNA genome.
Since both DNA synthesis and RNase H activities are
obligatory for the strand-transfer process, we tested the
efficiency of strand-transfer reactions with the two BIV RT
isoforms. Employing the in vitro strand transfer assay
previously performed (Gao et al., 1998; Sevilya et al., 2001,
2003), we show here that, indeed, the BIVenzymes are capable
of catalyzing a strand transfer reaction (Fig. 5). It is apparentFig. 5. Strand-transfer activity of BIV RT. Strand-transfer reactions containing
0.4 μg of purified RT were incubated at 37 °C for 60 min as described and the
reaction products were resolved by urea-PAGE (Sevilya et al., 2001). The strong
stop DNA transcript, which is nearly a full-length copy of the primary RNA, is
marked by (s) and is 139 nucleotides in length. The full-length transfer product
is marked by (t) and is 238 nucleotides in length. The reactions were performed
with either 8 mMMg+2 or with 0.8 mMMn+2. Lanes 1–5, the products obtained
in the presence of both the primary 267 nt RNA and the secondary 139 nt RNA.
Lanes 6–10, the products of control reactions performed without the secondary
RNA (required for the strand transfer). Lanes 1, 6, BIV RT1 in the presence of
Mg+2. Lanes 2, 7, BIV RT1 in the presence of Mn+2. Lanes 3, 8, BIV RT2 in the
presence of Mg+2. Lanes 4, 9, BIV RT2 in the presence of Mn+2. Lanes 5, 10,
HIV-1 RT in the presence of Mg+2. M, Molecular mass markers are HinfI-
cleaved ϕX174am3 DNA fragments (mentioned in Fig. 3).that BIV RT1 is more active than RT2, especially with Mg+2
and that for both isoforms the activity in the presence of Mg+2 is
better than the one in the presence of Mn+2. The amount of the
full-length 238 nt DNA synthesized, which represents the
transfer activity, was quantified and the transfer activity values
of BIV RT1 are higher (5%) than for BIV RT2 (3%) with the
preferable cation (Mg+2), and 3% versus 2% respectively with
Mn+2. These results are compatible with the fact that RT1 is
more active than RT2 in both DNA polymerase and RNase H
functions and that Mg+2 is usually the preferred divalent cation
(Table 2, Fig. 4 and Table 5). The transfer activity value
calculated here for HIV-1 RT (19.8%) is significantly higher
than those of BIV RTs and it is mainly due to the higher RNase
H activity of HIV-1 RT (Fig. 4 and Table 5). As in the case of the
novel BIV RT, a relatively weak RNase H and subsequently a
low strand transfer activity, were observed by us also for two
strains of HIV-2 RT (Sevilya et al., 2001, 2003). This lower
RNase H may not substantially affect the replication rates of
virions with a diminished RNase H activity, as it was found that
reducing RNase H activity had a lesser effect on viral replication
than reducing the DNA polymerase activity (Julias et al., 2001).
The fidelity of DNA synthesis
The fidelity of DNA synthesis was studied in vitro with
many retroviral RTs suggesting a relatively low fidelity of DNA
synthesis. Similar to all RTs studied so far, BIV RT lacks a
3′ → 5′ exonuclease proofreading activity (data not shown),
thereby permitting a direct kinetic analysis of primer extension.
It was shown that the primary parameters for fidelity (namely,
the 3′-end misinsertion and the extension of the preformed 3′-
end mispaired primers) depend largely on the sequences of
nucleic acids copied, rather than on whether DNA or RNA
templates are used (Bakhanashvili and Hizi, 1993a, 1993b;
Rubinek et al., 1997; Taube et al., 1998a). Consequently, we
have analyzed DNA templates, as representing both DNA and
RNA substrates.
The formation of 3′ mispaired DNA
The fidelity of misinsertion was studied in an assay system
that measures the standing-start reaction of 3′-end misinsertion.
This was done by following the misincorporation of incorrect
dNTPs opposite to the terminal template “A” nucleotide—in
comparison with the incorporation of dTTP (see Fig. 6A and
Fig. 6. The fidelity of misincorporation and mispair extension of BIV RT. (A) The pattern of site-specific nucleotide misinsertion: The synthetic 50-nucleotide template
was annealed to the [32P]-5′-end-labeled 15-nucleotide primer. The primer was extended with equal DNA polymerase activity of either BIV RT1, BIV RT2 or HIV-1
RT, in the presence of 1 mM of a single incorrect dNTP (i.e. C, G or A) or 1 μM of dTTP, as described in Materials and methods. (B) The pattern of extension of
preformed 3′-end mispaired DNA: the [32P]-5′-end-labeled 16-nucleotide primers were hybridized to the 50-nucleotide template. Four different duplexes were
produced, out of which three were the 3′-terminal preformed mismatches, where N represents the incorrect nucleotide (A, C or G) and the fourth is the matched duplex
(where N represents T). The primers were extended with equal DNA polymerase activities of BIV RT1, BIV RT2 or HIV-1 RT, in the presence of either 1 mM dATP
(when the mispaired template-primers were elongated) or 1 μM dATP (for the extension of the matched template-primer).
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Mg+2 that is the preferred divalent cation. BIV RT1 and BIV
RT2 (as well as HIV-1 RT) elongate the 5′-end-labeled primer
by one nucleotide in the presence of 1 mM dTTP with no further
extensions. The highest extent of misincorporation by the two
BIV RTs is obtained with dCTP, forming C–A mispair that is
further elongated to form C–T mispair. This is followed by the
correct C–G pair (18 nt) and by a C–T mispair (19 nt length).
With dGTP, the elongation is slightly lower than with dCTP,
forming a G–Amispair, which is further elongated to form G–T
(17 nt), G–G (18 nt) and C–T (19 nt) mispairs. With the wrong
dATP, there is very little misincorporation by BIV RTs, forming
an A–A mispair that, as expected, is fully elongated to form the
correct A–T pair (17 nt). It is apparent that the general pattern of
primer extension obtained with the two BIV RT isoforms is
quite similar to this with HIV-1 RT.
To quantify the capacity of BIV RTs to form 3′-end mispairs,
four sets of primer-extension reactions were carried out and
analyzed (each done with increasing concentrations of a single
dNTP), thereby determining the standing-start rate of synthesis
of the correct pair compared to the three possible mispairs. To
obey steady-state kinetic conditions, we have used a range of
dNTP concentrations below 1 mM and calculated theradioactivity in gel bands relative to the total amounts of
primers present (both the unextended and the extended ones).
The apparent Km and Vmax values for each dNTP derived from
the double-reciprocal curves of the initial velocities of primer
extension versus the substrate concentrations (not shown) are
presented in Table 6. The frequencies of misinsertion (Fins
values) were calculated from the formula:
Fins ¼ ðVmax=KmÞ
W
ðVmax=KmÞR
(W) stands for the wrong nucleotide (dATP, dCTP and
dGTP) and (R) denotes the dTTP. Therefore, the quantitative
evaluation of misincorporation is always normalized relative to
the activity of incorporating the right dNTP. As expected from
the results presented in Table 6, the highest Fins value calculated
for both BIV RTs is for dCTP (1/3200), whereas, the formation
of A–G mispair is moderately lower (Fins = 1/9900 and 1/3800)
and the Fins values for dATP incorporation is relatively rare (1/
34,700 and 1/18,200). It is also evident that the fidelity of
misinsertion by BIV RT1 is better than that calculated for RT2.
In comparison, the Fins values previously calculated in the same
assay system for HIV-1 RT were 1/3400–1/9000, 1/32,200–1/
Table 7
Kinetic parameters of the extension of 3′-end matched or preformed mismatched
primer termini by BIV RT isoforms
Pair extended Vmax (%) Km (μM) Fext
RT1
A·T 9.6 0.008 1
A·C 4.4 11 1/3000
A·G 5.4 31 1/6900
A·A 5.1 11 1/2600
RT2
A·T 6.9 0.015 1
A·C 3.6 15 1/1900
A·G 2.1 13 1/2800
A·A 3.4 16 1/2200
The 5′-end-labeled 16-nucleotide primers were hybridized to a 50-nucleotide
template (as described for Table 6). The duplexes produced were 3′-terminal
paired (A–T) or mispaired (A–C, A–G or A–A) primers (Fig. 6B). Each
template-primer was incubated with either BIV RT1 or BIV RT2 in the presence
of increasing concentrations of dATP. The products were analyzed as described
in the text. The apparent Km and Vmax values were determined from at least two
independent experiments and the variations were usually less than 10%. The
relative frequency Fext values are the ratio of the rate constants (Vmax/Km) for the
mispair divided by the ratio of the corresponding constants for the paired A–T
terminus.
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G and A–A mispairs, respectively (Bakhanashvili et al., 1996;
Rubinek et al., 1997). This indicates that both versions of the
BIV RT studied here are significantly more error prone than
HIV-1 RT.
Extension of preformed 3′-end mispaired DNA
The misincorporation of a nucleotide by itself is not adequate
to create site-specific mutations, unless the mispaired DNA
terminus is further extended to fix the wrong sequence.
Therefore, the effectiveness of extending 3′ preformed
mismatched primers is an essential factor in determining the
fidelity of DNA synthesis. The ability of the BIV RT isoforms to
extend preformed 3′-end mispaired 16-residue primers (A–A,
A–C, A–G) was assessed by analyzing the extension of these
primers, in the presence of the next complementary dATP (Fig.
6B). Both BIV RTs elongate all 5′-end-labeled mispairs by one
nucleotide with no substantial preference towards any specific
mispair DNA. The kinetics of the mispair extension was studied
by following primer elongation as a function of increasing
concentrations of dATP (Table 7). The ratios of all extended
products were calculated relative to the total amount of the
primers as a function of dATP concentration. The relative
extension frequency (Fext) values are defined as Vmax/Km
values (calculated for the preformed mismatches) divided by
the Vmax/Km value, obtained for the correctly paired A–T
terminus. The apparent Vmax values for the extension of all
three mispairs studied by BIV RT1 are similar and somewhat
higher than the comparable values calculated for BIV RT2. As
expected, the Km values calculated for the extension of the A–
A, A–C and A–G mismatches by the BIV RT isoforms are
much higher than the Km of the correct A–T pair. For RT1,
the Km value of the mispair A–G is higher and is the cause for
the relatively lower frequency of the elongation of this
preformed mismatch. The calculated frequencies of extensionTable 6
Kinetic parameters of the site-specific misincorporation by BIV RT isoforms
Mispair formed Vmax (%) Km (μM) Fins
RT1
A·T 19.9 0.025 1
A·C 6.8 27 1/3200
A·G 4.9 61 1/9900
A·A 1.7 74 1/34,700
RT2
A·T 9.9 0.043 1
A·C 4.4 62 1/3200
A·G 3.4 56 1/3800
A·A 1.0 79 1/18,200
The 15-residue 5′-end-labeled primer was hybridized to an excess of 50-residue
template that is derived from the sequence of nucleotides 565–614 of
ϕx174am3 DNA (Fig. 6A). In each set of the kinetic experiments, the
template-primer was incubated with either BIV RT1 or BIV RT2 in the presence
of increasing concentrations of a single dNTP. The oligonucleotide products
were analyzed as described in Materials and methods. The apparent Km and
Vmax values were determined from at least two independent experiments and the
variations were usually less than 10%. The values of relative frequency of
insertion (Fins) were calculated as described in the text.for A–A and A–C are higher for both BIV RT versions (about
1/2200, 1/1900 for RT2 and 1/2600, 1/3000 for RT1), whereas
the frequencies for A–G are slightly lower (about 1/3000 for
RT2 and 1/7000 for RT1). In all, BIV RT2 is slightly more
error prone than BIV RT1. The Fext values calculated
previously for HIV-1 RT in the same assay system were: 1/
1000, 1/11,400, 1/1200, for A–C, A–G and A–A mispairs,
respectively (Bakhanashvili et al., 1996).
Discussion
Unlike HIV and SIV, the BIV is a lentivirus of unknown
pathogenesis in infected cattle and buffalo and no virus-specific
disease has been yet identified in infected herds. Yet, in an
experimentally infected rabbits, the virus causes syndromes
similar to AIDS (Kalvatchev et al., 1995, 1998), implying its
potential importance in a novel AIDS-related animal model
system. The putative amino acid sequence of BIV RT shows
high homology to the sequence of the well-studied HIV-1 RT.
Thus, a pairwise alignment of the amino acids sequences of
these two RTs (Fig. 1) yields a score of 37 (Thompson et al.,
1994). Thirty-eight percent of the residues are identical and, on
top of that, 21% are homologous. Since RT is a key enzyme in
the life cycle of all retroviruses (Coffin et al., 1997; De Clercq,
1997; Skalka and Goff, 1993), investigating of BIV RT in
comparison to other known RTs (especially HIV-1 RT) may
help in understanding the variance in the pathogenesis of
different lentiviruses.
Two versions of the recombinant BIV RTs were cloned: RT1,
the 546 residues-long BIV recombinant protein and the longer
RT2, that includes at the carboxyl terminus an additional 74
residues segment and is altogether 620 residues long (Fig. 1). In
the absence of data from virus-synthesized RT and in order to
determine the optimal length of the BIV RT protein, we have
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comparative study of their catalytic and molecular properties.
The major conclusion is that the recombinant BIV RT1 is at
least as good a reverse transcriptase as RT2. In fact, the longer
BIV RT version has some significant disadvantages relative to
the shorter version of the RT, which can result from the
excessive sequence at the carboxyl terminus that might interfere
with the enzyme activity. Hence, we conclude that the short
version, which aligned quite well with HIV RTs and SIV RT, is
more likely to be closer to the authentic and biologically
relevant BIV RT.
The obvious question arising is what is the role of the 74
amino acids long peptide. Since the amino terminus of the
putative integrase of BIV aligns quite well with that of HIV-1
(Fig. 1), it might be that the 74 residues segment is associated
with another protein and/or another catalytic activity. Indeed,
several lentiviruses, such as FIV and EIAV, express a fourth
retroviral enzyme (additional to RT, IN and PR), namely a
dUTPase (Bergman et al., 1995; Olmsted et al., 1989). This
protein is encoded by a gene located between the RT and IN-
encoding segments, where the BIV-related 74 residue-encoding
segment is located. Interestingly, there is some homology
between the sequence of the 74 residues BIV segment and these
lentiviral dUTPases giving scores of 22 and 24 with the
sequences of the dUTPases of FIV and EIAV, respectively.
However, the FIV and EIAV dUTPases are about 130-residues
long, almost twice the length of the BIV segment; thus, the
likelihood that this 74 residues segment can possess such an
independent enzymatic activity is quite low. Moreover, other
retroviruses of the type B and type D family express another
kind of dUTPase as a transframe protein from the overlap
between the Gag and PR-encoding genes (Coffin et al., 1997;
Hizi et al., 1987; Koppe et al., 1994; Oda et al., 1988; York et
al., 1992). This dUTPase is significantly larger than the
lentiviral enzyme with 250–320 residues (depending on the
viral strain). Even the dUTPases of E. coli and Candida
albicans are about 150 residues long (Hayashi et al., 2001;
Jones et al., 2004), and as far as we know, there is no evidence
for an active 74 residues-long dUTPase. Still, all dUTPases
show a limited homology (with five conserved sequence motifs)
with the BIV protein segment (data not shown). It is likely,
however, that the 74 residues-long BIV-derived segment has a
biological role, since it is also found in another related bovine
lentivirus, the Jembrana disease virus (Chadwick et al., 1995). It
should be noted that all retroviral dUTPases are cleaved off the
precursor polyproteins by the viral PR and probably function as
independent enzymes. However, in our BIV RT-PR bacterial co-
expression system, the molecular size of the larger subunit of
RT2 is significantly larger than RT1 (Fig. 2), in agreement with
the expected size (except for the p69 version of BIV RT2—see
above). Therefore, it seems that, at least in this system, the 74-
residues segment is not removed from the RT by the BIV PR. It
might be that this segment has a novel regulatory role on BIV
RT, which is unknown in other studied RTs. To this end, we plan
to assay the RT2 protein for dUTPase activity and also to
express this independent segment and study its potential
activities.A processive event is defined as the ability of polymerase to
bind a polymeric substrate (DNA or RNA) and perform a
polymerization cycle without intervening dissociation. A total
processivity of synthesis of DNA or RNA is accomplished
when the entire template is copied as a consequence of only one
polymerase-binding event (Avidan and Hizi, 1998; Von Hippel
et al., 1994). Retroviral RTs are quite inefficient in performing
totally processive events (Avidan and Hizi, 1998; Avidan et al.,
2002, 2003; Taube et al., 1998a). However, the results shown
here (Fig. 3 and Table 4) indicate that these features of the BIV
RT isoforms are significantly higher than those of both HIV-1
RT and MLV RT. In the presence of Mg+2, the BIV RT isoforms
synthesize significant amounts of product DNA that, even with
an excess of unlabelled trap DNA, are longer than about 250 nt.
In comparison, in the presence of a DNA trap, HIV-1 RT
synthesizes only a small amount of product DNA that is longer
than 250 nt, while MLV RT generates products of only about up
to 100 nt. These differences between BIV RT and the two other
RTs may suggest that BIV RT binds better the DNA substrate
than most RTs studied including PERV RT and BLV RT
(Avidan et al., 2002, 2003). Taken together, BIV RT is a highly
processive retroviral RT and belongs together with MMTV RT
and AMV RT to a group of apparently more processive RTs
(Taube et al., 1998a). All RTs studied show the same premature
pausings, with or without trap DNA (Fig. 3), we concluded that
the pausings are sequence-dependent. It will be of interest to
study other sequences than those used here to identify any
unique sequence that cannot be copied easily by retroviral RTs.
DNA polymerases which lack the 3′ → 5′ proofreading
exonuclease activity are more error prone, explaining, at least in
part, why RTs have a lower fidelity than other DNA polymerases
(Bakhanashvili and Hizi, 1993a; Echols and Goodman, 1991;
Perrino et al., 1989; Taube et al., 1998a). Yet, a comparison of the
overall fidelity of DNA synthesis exhibited by RTs from
different retroviruses reveals significant differences among
them. The RTs of HIV-1 and HIV-2 were found to have a
relatively low fidelity of DNA synthesis compared to other RTs,
such as AMV, MMTV, EIAVor MLV (Bakhanashvili and Hizi,
1992; Bakhanashvili et al., 1996; Rubinek et al., 1997; Taube et
al., 1998a; Yu and Goodman, 1992). In general, the fidelity of
DNA polymerases results from the combination of nucleotide
insertion and extension in the presence or absence of
proofreading activity. Base substitutionmutations during reverse
transcription can arise from incorporation of a noncomplemen-
tary nucleotide at the 3′-end of the nascent DNA strand, followed
by an extension of the preformed mispair. The misinsertion
frequencies observed with both recombinant BIV RTs show an
error proneness that is higher than that observed with HIV-1 RT
(Fig. 6A and Table 6). As for the capacity of BIV RTs to elongate
preformed mispairs, it is apparent from Fig. 6B that BIV RTs
exhibit a pattern of extension roughly similar to that observed
with HIV-1 RT, except for A–C mispair extension that produces
longer products by HIV-1 RT. Accordingly, the Fext values
calculated for the BIV RT isoforms (Table 7) indicate that the
error proneness of the mispair extension by BIV RTs is
somewhat lower than that of HIV-1 RT (Bakhanashvili et al.,
1996; Rubinek et al., 1997). In all, the apparent low fidelity of
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BIV isolates, like those of other known lentiviruses, exhibit a
striking genomic diversity (Meas et al., 2001).
The RNase H domain is located in the carboxyl terminus of
the RTs. BIV RT1 and BIV RT2 differ in their carboxyl
terminus, RT2 has an addition of 74 residues. The RNase H
activity of RT1 is higher than that of RT2 (Fig. 4, Table 2 and
Table 5). It might be that the extra sequence at the carboxyl
terminus of RT2 interferes with the enzyme structure required
for an efficient RNA cleavage; still the cleavage pattern by both
isoforms is indistinguishable. Maybe the most interesting result
regarding the novel BIV RT is that it produces an RNase H
cleavage product (20 nt) that is significantly longer than the
segment generated by HIV-1 RT and for that matter by all
retroviral RTs studied so far. This finding suggests that the
molecular spatial distance between the DNA polymerase and
the RNase H active sites in the novel BIV RT is longer by 3 nt
than all other retroviral RTs. It should be noted, however, that in
the case of the RT from the LTR-retrotransposon Ty3, the
hydrolysis profile suggests an increased spatial distance
between the two catalytic domains (Rausch et al., 2000). On
the other hand, our very recent study with the RT of another
LTR-retrotransposon, Tf1, shows an RNase H cleavage pattern
similar to that generated by HIV-1 RT (unpublished results).
In all, we hope that this study of a novel BIV RTwill lead to a
better understanding of structure–function relationships in
lentiviral RTs. The fact that the 74 residues segment at the
carboxyl terminus of the constructed RT2 does not add to the
activities RT studied and, if anything, interferes to a certain
extent with most activities, leaves open the function of the
dUTPase-like sequence in the biology of BIV. Consequently,
we plan to study this issue and to test whether this sequence can
function as an independent protein or, as an independent protein
or as an integral part of RT and thus has a new role in regulating
RT activities.
Materials and methods
Plasmids construction for protein expression
We have expressed and studied two recombinant forms of
BIV RT, designated BIV RT1 and BIV RT2. The DNA
segments that encode the two RT isoforms were generated by
PCR using the plasmid pBIV127, which contains an infectious
proviral clone of BIV DNA (Braun et al., 1988) that was
generously provided by the “NIH AIDS Research and
Reference Reagent Program”. Both BIV RT versions were
designed to start with the same amino termini, whereas the
carboxyl terminus of RT2 is 74 amino acids longer than that of
RT1. These RT versions were expressed in E. coli by plasmids
similar to those used previously for the expression of the RTs of
HIV-1 and HIV-2 (Gao et al., 1998; Sevilya et al., 2001). All
synthetic BIV proteins-encoding genes were generated by PCR
with the high fidelity Dynazyme polymerase (purchased from
Finnzames) using the appropriate synthetic oligonucleotides.
The BIV RT1-encoding segment (nucleotides 2043–3681)
and the BIV PR-encoding DNA segment (nucleotides 1727–2042) were subcloned from the BIV proviral clone (Braun et al.,
1988) into the pT5M plasmid designated pT5m-6His-BIV RT1/
PR. First, the RT1-encoding gene (to which NcoI and NotI sites
as well as a stop codon were added) was subcloned by ligating
the NcoI–NotI cleaved PCR product into the NcoI–NotI cleaved
plasmid. Then, the PR-encoding gene was PCR-synthesized
with additional NotI andHindIII restriction sites, the appropriate
initiation and stop codons, as well as at its 5′-end segment with a
Shine–Dalgarno sequence (for the mRNA ribosome-binding
site), which is located between the NotI sequence and the ATG
initiation codon. This allows a simultaneous expression of both
RT and PR proteins from the single polycistronoic mRNA. The
plasmid was created by ligating the NotI–HindIII cleaved PR-
encoding gene into the NotI–HindIII linearized plasmid. The
BIV RT2-encoding segment (nucleotides 2043–3909) has an
internalNcoI site. Therefore, for the construction of the BIVRT2
expression plasmid, the PCR-synthesized DNA segment (to
which NcoI and NotI sites as well as a stop codon were added)
was cleaved with KpnI (located internally in the RT1/RT2
overlapping sequence at position 2105 of the provirus) and NotI
and introduced into the KpnI–NotI cleaved pT5m-6His-BIV
RT1/PR plasmid, thus replacing the BIV RT1-encoding gene
with the RT2-encoding segment. The BIV RT2-expressing
plasmid was designated pT5m-6His-BIV RT2/PR.
All subcloned BIV-related DNA segments were sequenced
to verify the authenticity of the expressed proteins. Each of
these constructed plasmids co-expresses both the BIV PR and
the RT1 or RT2. Therefore, the large RT subunit homodimers,
synthesized after the induction by isopropyl β-tiogalactopyr-
anoside (IPTG) in the E. coli strain BL21(DE3)pLysS, were
proteolytically processed in the expressing cells, leading to the
accumulation of heterodimeric RT molecules that are composed
each of the larger and smaller subunits (Boyer et al., 1994; Gao
et al., 1998; Le Grice and Gruninger-Leitch, 1990; Sevilya et
al., 2001). To allow a fast affinity purification of the
recombinant RTs, six-histidine tags were added to the amino
termini of both BIV RT versions. Consequently, after generating
the heterodimeric RT molecules, both the larger and smaller
subunits, of each version, have this tag on the amino termini.
The relative DNA polymerase activities
The DNA polymerase activities of BIV RT1 and RT2 were
analyzed and compared in the presence of 0.8 mM Mn+2 or
8 mM Mg+2 as the divalent cation. The DDDP reactions were
performed with the synthetic template-primers, poly(dA)n·oligo
(dT)12–18 and poly(dC)n·oligo(dG)12–18, or with herring sperm
activated gapped DNA, which was prepared as described
previously (Hizi et al., 1991b). The RDDP reactions were
performed with the synthetic template-primers, poly(rA)n·oligo
(dT)12–18 and poly(rC)n·oligo(dG)12–18. In addition, the appro-
priate dNTPs were added to the reaction mixtures along with
25 mM Tris–HCl, 40 mM KCl and either 8 mM MgCl2 or
0.8 mM MnCl2, final pH 7.5. Unless otherwise stated, the final
concentration of the synthetic template-primers was 5 μg/ml and
of the activated DNA 30 μg/ml, while the concentration of each
dNTP used was 25 μM. The specific catalytic activity of the
55O. Avidan et al. / Virology 351 (2006) 42–57DNA polymerases activities was calculated and is expressed in
pmol of dNTP incorporated into DNA in 30 min at 37 °C per μg
purified RT (Table 2).
DNA synthesis under processive and nonprocessive conditions
The reactions were performed as described by us before
(Avidan andHizi, 1998; Avidan et al., 2002, 2003). The enzymes
used have been calibrated to have equal DDDP activities with
ϕX174am3 as DNA template and the reactions were performed
in the presence of 8 mM Mg+2 or 0.8 mM Mn+2. The reaction
products were analyzed by electrophoresis through 8% poly-
acrylamid-urea gels, as described earlier (Bakhanashvili and
Hizi, 1992, 1993a, 1993b). The relative amounts of the labeled
extension products were determined from the autoradiograms
and the percentage of the total amounts (unextended and
extended) of the extended primers were calculated.
The RNase H activity
This activity was assayed by two methods. In the first, the
release of [3H]AMP from [3H]poly(rA)n annealed to poly(dT)n
(into the trichloroacetic acid-soluble fraction) was measured, as
previously described (Hizi et al., 1991a). In the second method,
we have followed the pattern of cleavage of the labeled 5′-end
267 nt RNA, synthesized from the pBLRA30 plasmid (as
described by Gao et al., 1998) and annealed to 30 nucleotides-
long oligomeric DNAwith a complementary sequence: 5′-TGG
GTT CCC TAG TTA GCC AGA GAG CTC CCA-3′ (see
scheme in Fig. 4). The reaction mixtures contained approxi-
mately 0.1 pmol of the [32P] 5′-end-labeled RNA transcript,
annealed to 0.4 pmol of the 30mer synthetic oligonucleotide
DNA. The 3′-end of the DNA oligonucleotide is complemen-
tary to the region starting 30 nt away from the 5′-end of the
RNA transcript. The reactions contained 50 ng of each purified
RT and were performed, analyzed and calculated as described
(Sevilya et al., 2001), except for the longer oligomeric DNA
used and the usage of either MnCl2 or MgCl2 (0.8 mM or 8 mM,
respectively).
Fidelity of DNA synthesis
The reactions were performed by monitoring the standing-
start misinsertion and mispair extension properties of the RTs,
using the same method and calculations as described before
(Bakhanashvili and Hizi, 1993a; Taube et al., 1998a). Site-
specific nucleotide misinsertion was assayed by following the
incorporation of dNTP opposite to the A residue at position 23
of a 50-nucleotide synthetic template (with a sequence derived
from nucleotides 565–614 of ϕX174am3 DNA), see Fig. 6A.
The [32P] 5′-end-labeled 15 residues primer was extended in the
presence of increasing concentrations of either 0–1 mM dTTP
or 0–1 mM of each incorrect dNTP (dATP, dCTP or dGTP). For
determining the mispair extension, four sets of 16-residue [32P]
5′-end-labeled primers were annealed to the same template used
in the misinsertion assays, producing duplexes with a 3′-termini
paired (A–T) or mismatched (A–C, A–G or A–A) primers.Primer elongation was measured as a function of increasing
concentrations of dATP, as the only dNTP present (0–1 mM
range for the mispaired A–A, A–C or A–G termini, or a 0–
1 mM range for the correct A–T terminus).
All fidelity reactions were incubated at 37 °C for either 2 min
(for the correct incorporation or the extension of the accurate
template-primer) or for 5 min (for misincorporation or extension
of preformed mismatched DNA). Kinetic reactions were
performed with an about 10-fold molar excess of template-
primer over enzyme to ensure steady-state kinetics at the linear
range. The reaction products were analyzed by electrophoresis
through sequencing gels and the band intensities were
quantified.
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